Osteoblastic Bone Lesions Developing During Treatment with Erlotinib Indicate Major Response in Patients with Non-small Cell Lung Cancer A Brief Report

J.S.W. Lind, P.E. Postmus, E.F. Smit

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)554-557
JournalJournal of Thoracic Oncology
Volume5
Issue number4
DOIs
Publication statusPublished - 2010

Cite this